Peptides
Body
Composition
Weight
Management
Recovery & Repair
Reproductive Health
& Tanning
Longevity
& Skin Care
Cognitive
Enhancement
Tesamorelin
Tirzepatide
TB-500
Kisspeptin
GHK-Cu
Selank
Ipamorelin
Semaglutide
BPC-157
Melanotan 2
Epithalon
Semax
CJC-1295
Retatrutide
NAD+
PT-141
DSIP
MOTS-C
5-Amino-1MQ
FRAG 176-191
Hexarelin
MK-677

CJC-1295: The Complete Guide to Dosage, Benefits, and Research in 2024

1.CJC-1295 Dosage Chart | Quick Breakdown

Purpose Dosage Range Frequency Administration
General Use 1000-2000 mcg 1-2x weekly Subcutaneous injection
Bodybuilding 2000-3000 mcg 1-2x weekly Subcutaneous injection
Anti-Aging 1000-1500 mcg 1-2x weekly Subcutaneous injection
Research 30-60 mcg/kg 1-2x weekly Subcutaneous injection

2. What is CJC-1295??

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue. Key points:

  • Also known as DAC:GRF (Drug Affinity Complex:Growth Hormone-Releasing Factor)

  • Composed of 30 amino acids

  • Molecular formula: C152H252N44O42

  • Molecular weight: 3367.954 g/mol

  • Developed by ConjuChem Biotechnologies

  • Modified form of GHRH (1-29) with improved pharmacokinetics, especially half-life

Table of Contents

3. CJC-1295 Mechanism of Action

CJC-1295 works through several mechanisms:

  1. Binds to GHRH receptors in the anterior pituitary gland

  2. Stimulates the pulsatile release of growth hormone

  3. Increases the amplitude of growth hormone pulses

  4. Enhances production of insulin-like growth factor 1 (IGF-1)

  5. Extends the half-life of GHRH through bioconjugation with albumin

  6. Maintains more consistent blood levels of growth hormone

4. Research Applications and Potential Benefits of CJC-1295

CJC-1295 and Growth Hormone Secretion

  • Increases plasma GH levels by 2- to 10-fold for 6 days or longer

  • Elevates plasma IGF-1 levels by 0.5- to 3-fold for 9 to 11 days

CJC-1295 and Body Composition

  • Potential to reduce body fat

  • May increase lean muscle mass

  • Could improve overall body composition

CJC-1295 and Recovery

  • May accelerate wound healing

  • Potential to enhance recovery from exercise and injuries

CJC-1295 and Sleep Quality

  • May improve sleep quality and duration

  • Potential to enhance deep sleep phases

CJC-1295 and Cognitive Function

  • Possible improvements in memory and mental clarity

  • Potential neuroprotective effects

5. CJC-1295 Dosage Guide

Dosing CJC-1295 for General Use

  • Typical dose: 1000-2000 mcg per week

  • Often divided into 1-2 doses

Dosing CJC-1295 for Bodybuilding

  • Higher dose: 2000-3000 mcg per week

  • Usually divided into 1-2 doses

Dosing CJC-1295 for Anti-Aging

  • Lower dose: 1000-1500 mcg per week

  • Often administered 1-2 times weekly

Dosing CJC-1295 for Research

  • Dose range: 30-60 mcg per kg of body weight

  • Typically administered 1-2 times weekly

6. How to Mix and Administer CJC-1295

  1. Use bacteriostatic water to reconstitute the lyophilized powder

  2. Add water slowly, allowing it to trickle down the side of the vial

  3. Gently swirl the vial to mix, avoid shaking to prevent protein denaturation

  4. Calculate the correct dosage based on concentration (e.g., 2000 mcg/ml)

  5. Use sterile syringes and needles for each injection

  6. Recommended needle size: 29-31 gauge, 1/2 inch length

7.CJC-1295 Administration Methods

CJC-1295 is typically administered via subcutaneous injection:

  • Common injection sites: abdomen (2 inches away from navel), thigh, or upper arm

  • Rotate injection sites to prevent irritation

  • Administer on an empty stomach or at least 2 hours after eating

  • For optimal results, avoid eating for 1-2 hours post-injection

8. CJC-1295 Combinations and Interactions

CJC-1295 + Ipamorelin

  • Popular combination for enhanced GH release

  • Typical dosage: 1000 mcg CJC-1295 + 300 mcg Ipamorelin, administered together

  • May increase GH release synergistically

CJC-1295 + GHRP-2 or GHRP-6

  • May provide complementary effects

  • Dosages should be adjusted when combined (typically 1000 mcg CJC-1295 + 100-200 mcg GHRP)

9. Where to Buy CJC-1295 Online | 2024 Edition

CJC-1295 is typically only available through licensed medical professionals or specialized research chemical suppliers. Always ensure you're obtaining CJC-1295 from a reputable source that provides third-party testing results.

10. s CJC-1295 Safe?

Generally considered safe when used as directed, but potential side effects include:

  • Injection site reactions (redness, swelling)

  • Headaches

  • Flushing

  • Nausea

  • Water retention

  • Increased insulin sensitivity

Long-term safety data is limited, and use should be monitored by a healthcare professional.

11. Is CJC-1295 Legal?

  • Not approved by the FDA for human use

  • Legal status varies by country and jurisdiction

  • Often restricted to research or medical use

  • Banned by WADA for competitive athletes

  • In the US, it's legal to possess for research purposes but not for human consumption

  • Always check local laws before purchasing or using CJC-1295

12. CJC-1295 Storage and Handling

  • Store lyophilized powder at room temperature (20-25°C or 68-77°F) away from light

  • Once reconstituted, store in the refrigerator (2-8°C or 36-46°F)

  • Use within 30 days after reconstitution

  • Do not freeze reconstituted CJC-1295

  • Always use sterile techniques when handling

13. Frequently Asked Questions (FAQ)

How long does it take to see results with CJC-1295?

Results may vary, but some users report noticeable changes within 4-8 weeks of consistent use. Improved sleep and recovery may be noticed within the first few weeks, while changes in body composition typically take 2-3 months to become apparent.

Can CJC-1295 be used for weight loss?

While not primarily a weight loss drug, CJC-1295 may contribute to fat loss as part of its effects on body composition and metabolism.

Is CJC-1295 safe for long-term use?

 Long-term safety data is limited. Use should be monitored by a healthcare professional. Some studies have shown safe use for up to 12 months, but regular health check-ups and blood tests are recommended.

What's the difference between CJC-1295 and CJC-1295 DAC?

CJC-1295 DAC includes a Drug Affinity Complex that extends its half-life to about 8 days, compared to the 30-minute half-life of regular CJC-1295.

14. CJC-1295 Dosage | Final Verdict

  • CJC-1295 shows promise as a potent growth hormone secretagogue with potential benefits for body composition, recovery, and anti-aging. The typical dosage range of 1000-3000 mcg per week appears effective for most applications, with specific dosages tailored to individual goals and responses.

  • Its ability to increase growth hormone levels for extended periods makes it an attractive option for those seeking the benefits of increased GH without the need for daily injections. However, its use should be approached cautiously due to limited long-term safety data and varying legal status.

  • Always consult with a healthcare professional before starting any peptide regimen, and ensure regular monitoring of health markers during use. As research continues, our understanding of CJC-1295's full potential and optimal use protocols may evolve.

15. References

  1. Teichman SL, et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.

  2. Ionescu M, Frohman LA. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792-4797.

  3. Sackmann-Sala L, et al. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6), 471-477.

  4. Alba M, et al. (2006). Once-weekly administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analogue, normalizes growth in growth hormone-deficient rats. Growth Hormone & IGF Research, 16(5-6), 326-334.

  5. Jetté L, et al. (2005). Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification

Disclaimer

Peptideresearcher.com contains information about products intended for research and laboratory use only, unless otherwise explicitly stated. All content is for educational purposes and is not meant to substitute for professional medical advice. Peptideresearcher.com strives to ensure that all information presented is accurate and complies with national and international standards, but it is not guaranteed. The content provided is not intended to diagnose, treat, cure, or prevent any disease or condition.

Peptideresearcher.com does not offer medical diagnoses or prescriptions. Any product information shared is solely for research purposes and should be used by qualified professionals only. We advise all users to consult with a healthcare professional before using any peptides, supplements, or medications mentioned on this site. All opinions expressed are those of the individual authors and may not reflect the opinions of Peptideresearcher.com.

Copyright 2024 - Peptide Researcher

Your access to Peptideresearcher.com is subject to our Terms of Use